Stephen Willey
Stock Analyst at Stifel Nicolaus
Total Price Targets
21
Stocks Covered
14
Sectors
Healthcare
Most Recent
Mar 17, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Stephen Willey
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| ABEO | Abeona Therapeutics Inc. | $17.00 | $5.42 | +213.4% | 2 | Mar 17, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $45.00 | $19.18 | +134.7% | 1 | Feb 27, 2026 |
| CBIO | Crescent Biopharma, Inc. | $29.00 | $18.44 | +57.3% | 2 | Feb 26, 2026 |
| INCY | Incyte Corporation | $120.00 | $96.41 | +24.5% | 2 | Feb 11, 2026 |
| JANX | Janux Therapeutics, Inc. | $38.00 | $14.35 | +164.9% | 1 | Dec 2, 2025 |
| ZYME | Zymeworks Inc. | $40.00 | $26.93 | +48.6% | 3 | Nov 19, 2025 |
| EXEL | Exelixis, Inc. | $43.00 | $43.81 | -1.8% | 1 | Nov 5, 2025 |
| XFOR | X4 Pharmaceuticals, Inc. | $7.50 | $4.20 | +78.6% | 2 | Nov 5, 2025 |
| ACLX | Arcellx, Inc. | $129.00 | $115.07 | +12.1% | 1 | Oct 16, 2025 |
| VOR | Vor Biopharma Inc. | $55.00 | $13.94 | +294.5% | 1 | Sep 24, 2025 |
| NRIX | Nurix Therapeutics, Inc. | $34.00 | $16.83 | +102.0% | 1 | Oct 14, 2024 |
| MGNX | MacroGenics, Inc. | $6.00 | $3.16 | +89.9% | 2 | Aug 7, 2024 |
| GERN | Geron Corporation | $7.00 | $1.58 | +341.6% | 1 | Jun 10, 2024 |
| INSM | Insmed Incorporated | $74.00 | $133.75 | -44.7% | 1 | Jun 5, 2024 |
Recent Activity
- Mar 17, 2026— Set$17.00price target onABEO(Abeona Therapeutics Inc.)
- Feb 27, 2026— Set$45.00price target onSNDX(Syndax Pharmaceuticals, Inc.)
- Feb 26, 2026— Set$29.00price target onCBIO(Crescent Biopharma, Inc.)
- Feb 11, 2026— Set$120.00price target onINCY(Incyte Corporation)
- Jan 5, 2026— Set$119.00price target onINCY(Incyte Corporation)
- Dec 4, 2025— Set$32.00price target onCBIO(Crescent Biopharma, Inc.)
- Dec 2, 2025— Set$38.00price target onJANX(Janux Therapeutics, Inc.)
- Nov 19, 2025— Set$40.00price target onZYME(Zymeworks Inc.)
- Nov 5, 2025— Set$7.50price target onXFOR(X4 Pharmaceuticals, Inc.)
- Nov 5, 2025— Set$43.00price target onEXEL(Exelixis, Inc.)
- Oct 16, 2025— Set$129.00price target onACLX(Arcellx, Inc.)
- Sep 24, 2025— Set$55.00price target onVOR(Vor Biopharma Inc.)
- Aug 29, 2025— Set$9.00price target onXFOR(X4 Pharmaceuticals, Inc.)
- May 16, 2025— Set$20.00price target onABEO(Abeona Therapeutics Inc.)
- Oct 28, 2024— Set$28.00price target onZYME(Zymeworks Inc.)
- Oct 14, 2024— Set$34.00price target onNRIX(Nurix Therapeutics, Inc.)
- Sep 10, 2024— Set$21.00price target onZYME(Zymeworks Inc.)
- Aug 7, 2024— Set$6.00price target onMGNX(MacroGenics, Inc.)
- Jun 10, 2024— Set$7.00price target onGERN(Geron Corporation)
- Jun 5, 2024— Set$74.00price target onINSM(Insmed Incorporated)
Frequently Asked Questions
Who is Stephen Willey?
Stephen Willey is a stock analyst at Stifel Nicolaus covering 14 stocks primarily in Healthcare. They have issued 21 price targets since Apr 4, 2024.
What stocks does Stephen Willey cover?
Stephen Willey currently covers 14 stocks, including ZYME, ABEO, CBIO, INCY, XFOR.
What is Stephen Willey's latest price target?
Stephen Willey's most recent price target was $17.00 on ABEO (Abeona Therapeutics Inc.), set on Mar 17, 2026.
What is Stephen Willey's highest price target?
Stephen Willey's highest issued price target is $129.00 on ACLX, set on Oct 16, 2025.
More Analysts at Stifel Nicolaus
Coverage based on publicly published price targets. Not investment advice.